Новости компании

Chromis, a joint venture of the Russian Direct Investment Fund (RDIF) and ChemRar Group, was rated by Rospatent among ...
17.06.2021
The high efficacy of Avifavir®, the first registered drug for the treatment of COVID-19, in clinical practice was ...
08.06.2021
Indonesia registers Russian drug with proven clinical efficacy against coronavirus Avifavir was the first ...
24.03.2021
Chromis (Russia), a joint venture of the ChemRar Group and the Russian Direct Investment Fund (RDIF), and its partner ...
10.03.2021
Ajax Call Form
Loading...